Tivic Health (Nasdaq:TIVC) announced today that it regained compliance with the minimum bid price requirement on the Nasdaq market. Earlier this year, San Francisco-based Tivic filed an SEC Form 8-K pertaining to a notice of delisting from the Nasdaq market. The company received notice in January that its closing price fell below $1 for 30 […]
Bioelectronic Medicine
Boston Scientific targets M&A, AI to reach ‘next level’
Mike Mahoney uses fantasy football to describe Boston Scientific : He says that, if creating a medtech team, “it would be the draft you want.” Speaking at the company’s 2023 Investor Day event, the CEO set the theme as “next level.” He explained his aim to make Boston Scientific a “compelling” and “fantastic place to […]
InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system
InBrain Neuroelectronics announced today that it received FDA breakthrough device designation for its intelligent network modulation system. The breakthrough nod covers the graphene-neural platform as an adjunctive therapy for treating Parkinson’s disease. InBrain’s system harnesses the power of graphene, a two-dimensional material made of a lattice of carbon atoms. The thin material — stronger than […]
Motif Neurotech completes first-in-human implant of miniature brain pacemaker
Motif Neurotech today announced new research highlighting the use of its millimeter-sized brain stimulator in a human subject. Houston-based Motif Neurotech develops a miniature brain pacemaker designed to precisely stimulate the brain. It restores healthy circuit activity to treat mental health disorders. The pea-sized implant, which goes in during a 20-minute outpatient procedure, has capabilities […]
Tivic Health begins non-invasive, bioelectronic vagus nerve stimulation trial
Tivic Health (Nasdaq:TIVC) announced today that its funded study for vagus nerve stimulation received Institutional Review Board (IRB) approval. San Francisco-based Tivic Health’s study takes place at the Feinstein Institutes for Medical Research. With IRB approval, the company can begin recruitment and enrollment for the study of its non-invasive bioelectronic nerve stimulation device. In collaboration with […]
Tivic Health prices $1.4M common stock offering ahead of special stockholder meeting
Tivic Health (Nasdaq:TIVC) announced that it priced a public offering of common stock at $1.4 million. San Francisco-based Tivic intends to offer 33.173 million shares of common stock at $0.041 per share. The company plans to use the net proceeds for working capital and general corporate purposes. Tivic expects the offering to close on or […]
Tivic Health reduces workforce as it may face Nasdaq delisting
Tivic Health (Nasdaq:TIVC) CEO Jennifer Ernst issued a letter to investors updating them on the current situation at the bioelectronic medicine developer. Ernst’s letter included the announcement that the company took several measures to fortify its position. That includes a reduction in force and internal restructuring. The company did not disclose further details about the […]
NeuroOne prices $5.25M public offering
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering. Eden Prairie, Minnesota-based NeuroOne’s offering includes 5.25 million shares of common stock priced at $1 per share. All shares included in the offering will be sold by the company. NeuroOne also granted the underwriter a 30-day option to purchase up to […]
Medtronic neuromod vet joins miniature brain pacemaker developer Motif Neurotech as CTO
Minimally invasive bioelectronic maker Motif Neurotech announced today that it named Steven Goetz as its chief technology officer (CTO). Goetz joins after spending more than 26 years in the Neuromodulation unit at Medtronic. There, he led engineering and innovation initiatives for implantable device therapies for a wide range of diseases. Houston-based Motif Neurotech develops a […]
First patients treated in trial of Magnus Medical neurostim for depression
Magnus Medical announced today that it treated the first patients in the open-label optimization clinical trial for its Saint technology. The OLO trial evaluates the effectiveness of Saint technology for the treatment of major depressive disorder (MDD). The platform delivers individualized, rapid-acting, non-invasive neurostimulation. Saint treats adults who fail to achieve satisfactory improvement from prior antidepressant […]
Aetna policy update expands access to Neuronetics NeuroStar
Neuronetics (Nasdaq:STIM) announced today that a healthcare policy update from Aetna increases access to its NeuroStar therapy. Malvern, Pennsylvania-based Neuronetics develops products aimed at improving the life of patients with neuro health disorders. NeuroStar, a non-drug, non-invasive treatment can improve the quality of life for neuro health patients when traditional medication fails. The transcranial magnetic […]
